Cargando…
Dexamethasone intravitreous implant vs bevacizumab for central retinal vein occlusion‐related macular oedema: A prospective randomized comparison—Comment
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767533/ https://www.ncbi.nlm.nih.gov/pubmed/30801910 http://dx.doi.org/10.1111/ceo.13483 |
| _version_ | 1783454940230844416 |
|---|---|
| author | Wen, Dejia Li, Xiao‐Rong He, Ye Ren, Xinjun Zheng, Chuanzhen |
| author_facet | Wen, Dejia Li, Xiao‐Rong He, Ye Ren, Xinjun Zheng, Chuanzhen |
| author_sort | Wen, Dejia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6767533 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | John Wiley & Sons Australia, Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67675332019-10-03 Dexamethasone intravitreous implant vs bevacizumab for central retinal vein occlusion‐related macular oedema: A prospective randomized comparison—Comment Wen, Dejia Li, Xiao‐Rong He, Ye Ren, Xinjun Zheng, Chuanzhen Clin Exp Ophthalmol Letters to the Editor John Wiley & Sons Australia, Ltd 2019-04-01 2019-07 /pmc/articles/PMC6767533/ /pubmed/30801910 http://dx.doi.org/10.1111/ceo.13483 Text en © 2019 The Authors. Clinical & Experimental Ophthalmology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Ophthalmologists This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Wen, Dejia Li, Xiao‐Rong He, Ye Ren, Xinjun Zheng, Chuanzhen Dexamethasone intravitreous implant vs bevacizumab for central retinal vein occlusion‐related macular oedema: A prospective randomized comparison—Comment |
| title | Dexamethasone intravitreous implant vs bevacizumab for central retinal vein occlusion‐related macular oedema: A prospective randomized comparison—Comment |
| title_full | Dexamethasone intravitreous implant vs bevacizumab for central retinal vein occlusion‐related macular oedema: A prospective randomized comparison—Comment |
| title_fullStr | Dexamethasone intravitreous implant vs bevacizumab for central retinal vein occlusion‐related macular oedema: A prospective randomized comparison—Comment |
| title_full_unstemmed | Dexamethasone intravitreous implant vs bevacizumab for central retinal vein occlusion‐related macular oedema: A prospective randomized comparison—Comment |
| title_short | Dexamethasone intravitreous implant vs bevacizumab for central retinal vein occlusion‐related macular oedema: A prospective randomized comparison—Comment |
| title_sort | dexamethasone intravitreous implant vs bevacizumab for central retinal vein occlusion‐related macular oedema: a prospective randomized comparison—comment |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767533/ https://www.ncbi.nlm.nih.gov/pubmed/30801910 http://dx.doi.org/10.1111/ceo.13483 |
| work_keys_str_mv | AT wendejia dexamethasoneintravitreousimplantvsbevacizumabforcentralretinalveinocclusionrelatedmacularoedemaaprospectiverandomizedcomparisoncomment AT lixiaorong dexamethasoneintravitreousimplantvsbevacizumabforcentralretinalveinocclusionrelatedmacularoedemaaprospectiverandomizedcomparisoncomment AT heye dexamethasoneintravitreousimplantvsbevacizumabforcentralretinalveinocclusionrelatedmacularoedemaaprospectiverandomizedcomparisoncomment AT renxinjun dexamethasoneintravitreousimplantvsbevacizumabforcentralretinalveinocclusionrelatedmacularoedemaaprospectiverandomizedcomparisoncomment AT zhengchuanzhen dexamethasoneintravitreousimplantvsbevacizumabforcentralretinalveinocclusionrelatedmacularoedemaaprospectiverandomizedcomparisoncomment |